John D. Halpern 13D and 13G filings for Eterna Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 9:13 pm Purchase |
2025-03-31 | 13G | Eterna Therapeutics Inc. ERNA |
John D. Halpern | 5,971,830 9.600% |
835,249 (+16.26%) |
Filing |
| 2025-02-14 8:36 pm Purchase |
2024-10-29 | 13G | Eterna Therapeutics Inc. ERNA |
John D. Halpern | 5,136,581 9.990% |
5,136,581 (New Position) |
Filing |